CEMI

Chembio Diagnostics Stock Price

2.72
-0.25 (-8.42%)
2.72

Low
2.06

52 Week Range

High
8.75

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Chembio Diagnostics Inc CEMI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -8.42% 2.72 18:50:06
Open Price Low Price High Price Close Price Prev Close
2.96 2.63 2.97 2.75 2.97
Bid Price Ask Price Spread News
2.73 2.74 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
18,928 7,312,402 $ 2.78 $ 20,302,242 - 2.06 - 8.75
Last Trade Time Type Quantity Stock Price Currency
18:45:35 10 $ 2.72 USD

Period:

Draw Mode:

Chembio Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 55.21M 20.30M 19.96M $ 30.45M $ -21.48M -1.35 -2.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 11.50%

more financials information »

Chembio Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CEMI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.397.342.064.92116,203,2610.3313.81%
1 Month3.127.342.064.9130,800,901-0.40-12.82%
3 Months3.877.342.064.8510,443,451-1.15-29.72%
6 Months6.768.362.065.087,433,388-4.04-59.76%
1 Year5.108.752.065.124,868,214-2.38-46.67%
3 Years11.1516.202.065.312,106,995-8.43-75.61%
5 Years6.3916.202.065.321,282,987-3.67-57.43%

Chembio Diagnostics Description

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.


Your Recent History
NASDAQ
CEMI
Chembio Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.